Broncho-Vaxom is an oral immunostimulant containing extracts from eight bacterial pathogens frequently responsible for respiratory tract infections. We describe studies showing the mechanism by which Broncho-Vaxom stimulates the immune system and clinical trials in children and adults showing a decrease in the incidence of respiratory tract infections, their severity and duration and also economic effectiveness of the therapy.